SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-18-028187
Filing Date
2018-05-14
Accepted
2018-05-14 16:11:27
Documents
4
Period of Report
2018-05-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv494006_8k.htm 8-K 17159
2 EXHIBIT 99.1 tv494006_ex99-1.htm EX-99.1 65228
3 GRAPHIC image_001.jpg GRAPHIC 6074
4 GRAPHIC image_002.jpg GRAPHIC 5911
  Complete submission text file 0001144204-18-028187.txt   100425
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50626 | Film No.: 18830700
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1